Home » Topics » Disease categories and therapies » Urology

Urology
RSS

FDA denies Urigen's request for end-of-phase II meeting on URG-101

July 7, 2010

Phase II data support use of SFP in hemodialysis-dependent patients with CKD

July 7, 2010

Novel PDE5A inhibitors claimed by Chinese scientists

July 6, 2010

SBR-759 superior to sevelamer HCI for hyperphosphatemia in Asian hemodialysis patients

July 6, 2010

First patient receives CRMD-001 in phase II trial

June 30, 2010

Concert Pharmaceuticals claims new deuterated agents

June 28, 2010

Nymox nears completion of follow-up study of NX-1207 for BPH

June 23, 2010

Astellas submits MAA for mirabegron in Japan

June 22, 2010

Relypsa begins phase II trial of RLY-5016 for hyperkalemia

June 18, 2010

VIVUS' avanafil improves ED in phase III trial in diabetic men

June 9, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 5, 2026.
New York University identifies new analogues of mannose-6-phosphate
BioWorld Science
New York University has discovered new analogues of mannose-6-phosphate reported to be potentially useful for the treatment of memory impairment,...
FB-7033 demonstrates efficacy in MASH management
BioWorld Science
17-β-Hydroxysteroid dehydrogenase 13 (HSD17B13) and lipid transferase CIDEB are known to contribute to metabolic dysfunction-associated steatohepatitis (MASH)...
Preclinical results support Actinium’s radioconjugate ATNM‑400 for NSCLC
BioWorld Science
At the recent meeting of the Society of Nuclear Medicine and Molecular Imaging, researchers from Actinium Pharmaceuticals Inc. presented preclinical efficacy data...
Bial-Portela discovers new OX1 receptor antagonists
BioWorld Science
Bial-Portela & Ca SA has patented new orexin OX1 receptor antagonists potentially useful for the treatment of anxiety disorders, depression, eating disorders,...